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This work used eleven Peruvian snake venoms (Bothrops andianus, Bothrops atrox, Bothrops barnetti,
Bothrops castelnaudi, Bothriopsis chloromelas, Bothrocophias microphthalmus, Bothrops neuwiedi,
Bothriopsis oligolepis, Bothriopsis peruviana, Bothrops pictus and Bothriopsis taeniata) to perform in vitro
experimentation and determine its main characteristics. Hyaluronidase (HYAL), phospholipase A2
(PLA2), snake venom metalloproteinase (SVMP), snake venom serine protease (SVSP) and L-amino acid
oxidase (LAAO) activities; toxicity by cell viability assays using MGSO3, VERO and HeLa cell lineages; and
crossed immunoreactivity with Peruvian (PAV) and Brazilian (BAV) antibothropic polyvalent antivenoms,
through ELISA and Western Blotting assays, were determined. Results show that the activities tested in
this study were not similar amongst the venoms and each species present their own peculiarities,
highlighting the diversity within Bothrops complex. All venoms were capable of reducing cell viability of
all tested lineages. It was also demonstrated the crossed recognition of all tested venoms by both
antivenoms.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Of all accidents with venomous animals taking place in Peru,
ophidism is the main cause of death (Martinez-Vargas, 2004). Most
of the reported accidents occur within forest regions, since Peru-
vian Amazonia forest takes 58% of the country's territory, but areas
within coast regions and Andes Mountains also present endemic
medically relevant species. The great diversity of venomous snakes
in Peru represents a great potential risk of ophidic accidents. In
2013, 2143 accidents with venomous snakes were recorded, ac-
cording to the Peruvian National Institute of Health. Envenoming
cases often occur in secluded areas, posing difﬁculties in registering
properly the actual incidence and morbidity/mortality rates.
Therefore, available epidemiological data may be underestimatedica-Imunologia, Instituto de
rais, Belo Horizonte, CP: 486.
lortegui).(Ministerio de Salud de Peru, 2003). In addition, many native
venomous snake species remain poorly studied, in spite of the
acknowledged richness of Peruvian herpetofauna. The National
Institute of Health of Peru (INS) has been collecting venom from
those native snakes, to encourage further research.
The Bothrops complex (following taxonomy classiﬁcation pro-
posed by Carrasco et al., 2012; comprising Bothrops, Bothrocophias,
Bothriopsis, Bothropoides e Rhinocerophis subgroups) is responsible
for the vast majority of the accidents involving venomous snakes in
Peru (Fig. 1). Classic bothropic envenoming involves local and sys-
temic effects. Locally, edema, hemorrhage and necrosis can lead to
tissue loss and permanent disability. Systemic hemorrhage and
intravascular coagulopathy can lead to acute kidney injury and
cardiovascular shock and are the principal systemic complications
(White, 2005; Albuquerque et al., 2013). The mentioned effects
result from the integrated action of several venom components,
such as metallo proteases (known as Snake Venom Metallo Pro-
teases e SVMP), serine proteases (Snake Venom Serine Proteases e
SVSP), phospholipases A2 (PLA2), L-amino acid oxidase (LAAO),
Fig. 1. Distribution of ophidic accidents in Peru, according to snake genus. Reports of
accidents to the National Institute of Health from Peru (INS) in the year of 2013.
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of molecules are well characterized as the main bothropic venom
components, their relative abundance and speciﬁcity within
different species venoms (or even individuals) are subjected to
variations according to different parameters, such as age and
geographic localization (Calvete et al., 2011).
Studying venom properties of less known snakes is scientiﬁcally
relevant to improve medical management of accidents and to drive
antivenom production (Calvete et al., 2014). Moreover, snake
venoms are rich in molecules with interesting pharmacological
actions, being a valuable source for research in drug discovery
(King, 2011).
In vitro methods for venom characterization are available and
can provide relevant information. In addition of being more ethical,
in vitro tests can be cheaper, faster, easily standardized and are not
subjected to the inherent variation present in living animals.
Animal-free approaches in venom characterization studies,
although less frequent than research involving in vivo tests, have
been performed (Lopes-de-Sousa et al., 2015) and must be pursued
by scientiﬁc community, following the principle of the 3R
(Replacement, Reduction and Reﬁnement) in animal experimen-
tation (Flecknell, 2002).
Here, we present the characterization of six venom snakes of the
genera Bothrops (Bothrops andianus, Bothrops barnetti, Bothrops
castelnaudi, Bothrops neuwiedi, Bothrops pictus and Bothrops atrox),
four species of genera Bothriopsis (Bothriopsis chloromelas,
Bothriopsis oligolepis, Bothriopsis peruviana, and Bothriopsis tae-
niata) and one species of genera Bothrocophias (Bothrocophias
microphthalmus), using an animal-free approach.
2. Materials and methods
2.1. Venoms and antivenoms
Crude venoms from B. andianus, B. atrox, B. barnetti,
B. castelnaudi, B. chloromelas, B. microphthalmus, B. neuwiedi,
B. oligolepis, B. peruviana, B. pictus and B. taeniatawere provided by
the Instituto Nacional de Salud (INS), located in Lima, Peru and
crude venom from Bothrops jararaca, used as control, was provided
by Fundaç~ao Ezequiel Dias (FUNED), located in Belo Horizonte,
Brazil. All venoms were manually extracted from a pool of in-
dividuals, lyophilized and kept at 20 C until use. Five milligrams
of each venom pool were diluted in 1 mL of deionized water and its
protein content was determined with Bio Rad DC™ Protein Assay.
Peruvian anti-bothropic polyvalent anti-venom (PAV), produced
from horse plasma previously immunized with a deﬁned pool of
venoms [B. atrox (50%), B. pictus, B. barnetti, B. brazili andBothrocophias hyoprora (12.5%each)] was provided by INS. Brazilian
anti-bothropic polyvalent anti-venom (BAV) produced from horse
plasma previously immunized with a deﬁned pool of venoms [B.
jararaca (50%), Bothrops jararacussu, Bothrops alternatus, Bothrops
neuwiedi and Bothrops moojeni (12.5%each)], was provided by
Instituto Butantan, S~ao Paulo, Brazil. Antivenoms were kept at 4 C
as indicated on their prescription.
2.2. Enzymatic activities
2.2.1. Hyaluronidase
For quantifying hyaluronidase activity, dilution curves from 120
to 0.625 mg of each Peruvian species venom were incubated in ac-
etate buffer (0.2M sodium acetateeacetate acid and 0.15MNaCl, pH
6.0) with 12.5 mg of hyaluronic acid (HA) in 96-well microtiter
plates (Horta et al., 2014; with modiﬁcations). A control curve was
made with 5 points of known HA concentrations, corresponding to
0%, 25%, 50%, 75% and 100% of hyaluronidase activity. The plate was
incubated at 37 C for 15 min. After the incubation, 200 mL of a
solution containing 2.5% (w/v) cetyltrimethylammoniumbromide
(CTAB) dissolved in 2% (w/v) NaOH were added to each well and
produced turbidity was measured at 405 nm in microplate reader
Biorad Model 680. All assays were performed in duplicates. Results
from four independent experiments were plotted as means in a
doseeresponse curve and values for 50% activity were determined.
2.2.2. Phospholipase A2
To analyze phospholipase A2 activity, the EnzChek® Phospholi-
pase A2 Assay Kit (Life Technologies) was used. The experiment was
made following EnzCheck's protocol, using 2 mg of each Bothrops
spp. venoms. A solution of puriﬁed PLA2 from bee venom (10 units/
ml) in 1X PLA2 reaction buffer was used as positive control and the
same buffer without PLA2 was considered the negative control. All
assayswere performed in duplicates. Means of the results from four
independent experiments were calculated and plotted as percent-
age of activity, relating to the positive control.
2.2.3. Proteolytic activities (SVMP and SVSP)
To measure snake venom metalloprotease activity (SVMP), a
FRET peptide (Abz-LVEALYQ-EDDnp) containing the speciﬁc
cleavage site for these enzymes, previously produced by our group
(Schneider et al., 2014) was used. Twenty microliters of the FRET
peptide diluted in 60 mL of TriseHCl 100 nM/NaCl 50 nM buffer was
incubated with 1 mg of each Peruvian Bothrops venoms. After
30 min of incubation, the plate was read in ﬂuorometer (Synergy,
BioTek) at 340 nm for excitation and 440 nm for emission. Results of
means of three independent experiments were plotted as arbitrary
units of ﬂuorescence.
To measure the snake venom serine protease (SVSP) activity,
venoms were pre-incubated with EDTA 0.2 mM for 1 h minutes and
then followed the same protocol described above, using a FRET
peptide with the speciﬁc active site for serine proteases (Abz-
FLPRSFRQ-EDDnp). All assays were performed in duplicates. Results
of means three independent experiments were plotted as arbitrary
units of ﬂuorescence.
2.2.4. L-amino acid oxidase (LAAO)
For L-amino acid oxidase (LAAO) activity quantiﬁcation, 2 mg of
each Bothrops sp. venomwere incubated with a solution containing
L-leucine as substrate, 2 mM OPD (o-phenylenediamine dihydro-
chloride) and peroxidase (5U/mL) in 100 mM Tris- HCl buffer (pH
8.5), in 96 wells microtitre plates, at 37 C. After one hour of in-
cubation, the reaction was stopped by adding 50 mL of H2SO4 2M.
The reaction was measured by the absorbance intensity at 490 nm,
in microplate reader Biorad Model 680. Four independent assays
C. Guerra-Duarte et al. / Toxicon 108 (2015) 84e9686performed in duplicates were made (Bregge-Silva et al., 2012; with
slight modiﬁcations) and one unit of LAAO activity was considered
as the amount of venom that produced 1 mmol of H2O2 per minute,
under these speciﬁc conditions.
2.3. Cytotoxicity
MGSO-3 cell line, derived from human breast cancer tissue was
used (Correa et al., 2009). These cells were characterized, immor-
talized and provided by Correa group. VERO (from normal epithelial
monkey kidney) and HeLa (from human cervical adenocarcinoma)
cells were also used, since they are already the standardized cell
lines for viability assays. All cell lines were cultured in Dulbecco's
Modiﬁed Eagle's (DMEM, SigmaeAldrich, St. Louis, MO, USA) sup-
plemented with 10% fetal bovine serum (Thermo Scientiﬁc-
HyClone), 0.2% gentamicin (Gilbco by Life Technologies) and kept
in controlled atmosphere (10% CO2 incubator at 37 C).
For venom cytotoxicity evaluation (Damico et al., 2007; with
modiﬁcations), Alamar Blue® assay was conducted. Previously to
the assay,104 cells/well of either MGSO3, VERO or HeLawere plated
in 96-wells plates for 24 h at 37 C and 10% CO2. Then, the cells were
incubated under the same conditions with different amounts of
Peruvian Bothrops venoms for 24 h. A dilution curve of the venoms
was made from 80 mg/mL to 1.25 mg/mL. After incubation period,
Alamar Blue®was diluted in DMEMwith a concentration of 10% v/v
and added to eachwell. The platewas incubated for another 3 h and
then the values were measured in ﬂuorometer Synergy 2 (Bio-tek)
at 540 nm for excitation and 590 nm for emission. The software
GraphPad Prism 5was used to calculate the CD50 (amount of venom
able to reduce in 50% cell viability) for each venom, using results of
three independent experiments, performed in duplicates.
2.4. ELISA
Microtitre plates were coated with 100 ml of a solution con-
taining 1 mg/well in carbonate buffer, pH 9.8 of Peruvian Bothrops
venoms and incubated overnight at 4 C. The plate was washed and
then blocked with 100 mL/well of a solution of 3% skimmed milk in
PBS and incubated at 37 C for one hour. After washing, either
Peruvian anti-bothropic polyvalent anti-venom (PAV), Brazilian
anti-bothropic polyvalent anti-venom (BAV) or pre-immune horse
serum (PI) were diluted from 1/500 to 1/508,000 in a ﬁnal volume
of 100 mL, in 0.01% milk-PBS and again the plate was incubated at
37 C for an hour. The plate was washed and the secondary anti-
body (anti-horse peroxidase, diluted to 1/6000 with incubation
buffer), was added in a ﬁnal volume of 100 mL and incubated at
37 C for one hour. SigmaFast OPD tablets detected recognition,
according to manufacturer's instructions. The plate was incubated
in the dark for 20 min. After that, 20 mL of H2SO4 2M was added to
eachwell to stop the reaction. Absorbance at 492 nmwasmeasured
in microplate reader Biorad Model 680.
2.5. SDS-PAGE and Western Blot
Twenty micrograms of Bothrops spp. venoms were diluted in
sample buffer and separated in 12.5% SDS-PAGE gel, according to
Laemmli,1970. The gel ran for 30min at 50 V and then at 150 V until
the end. The gel was stained with silver or transferred to nitrocel-
lulose membranes for immunoblotting (Towbin et al., 1979). The
nitrocellulose membrane containing the transferred proteins was
blocked with PBS-Tween 0.3% for 1 h. After washing three times for
5 min with PBS-Tween 0.05%, the membrane was incubated with
either pre-immune serum, Peruvian anti-bothropic polyvalent
anti-venom (PAV) or Brazilian anti-bothropic polyvalent anti-
venom (BAV), diluted 1/5000 for 1 h. The membrane was washed(PBS-Tween 0.05%) three times and immunoreactive proteins were
detected using anti-horse IgG conjugated to peroxidase for 1 h at
room temperature. After washing three times for 5 min with PBS-
Tween 0.05%, blots were developed using DAB/chloronaphthol ac-
cording to manufacturer's instructions (SigmaeAldrich).
3. Results
3.1. Enzymatic activities
Enzymatic activities of the eleven studied species of Bothrops
venoms are summarized in Fig. 2. B. jararaca venom was used as a
reference for all the performed experiments. Fig. 2A shows the
results for the hyaluronidase activity test, expressed as the amount
of venom needed to degrade 50% of the hyaluronic acid present in
the solution. The results show that Bothriopsis oligolepis venom
requires the smallest dose to achieve 50% activity.
B. microphthalmus venom has the lowest hyaluronidase activity,
needing more than 100 mg to degrade 50% of the hyaluronic acid
available. It was not possible to detect any hyaluronidase activity in
B. andianus venom, even at very high concentrations (>200 mg/
well), in the conditions used in this assay.
As shown on Fig. 2B, B. atrox had the highest PLA2 activity
among the tested species, followed closely by B. taeniata and
B. pictus. Three of the twelve species tested had a result close to zero
(Bothrops castelnaudi, Bothriopsis chloromelas and B. oligolepis),
indicating very low PLA2 activity within these conditions.
Analyzing speciﬁc metalloprotease activity over FRET substrate
(Fig. 2C), B. atrox presented the highest activity among the studied
Peruvian venoms. B. castelnaudi was the least active venom, with a
result close to zero, but B. chloromelas, B. oligolepis and B. taeniata
also presented very low results.
For the serine protease assay (Fig. 2D), B. andianus had the
highest result, with B. chloromelas, B. oligolepis, B. peruviana and
B. taeniata presenting similar values, which were considerably
higher than B. jararaca controls. On the other hand, B. barnetti
presented the lowest activity.
In LAAO quantiﬁcation assay (Fig. 2E), the species B. chloromelas
showed the highest reactivity, presenting 14 units per mg per
minute of the active form of the enzymes L-amino acid oxidase. The
species that presented the lowest LAAO activity was B. barnetti,
with less than two units of the enzyme L-amino acid oxidase.
3.2. Cytotoxicity
Concerning cytotoxicity (Fig. 3), three different cell lineages
(MGSO3, VERO and HeLa) were tested against a serial dilution
(80 mg/ml to 1.25 mg/ml) of the Peruvian venoms. Although there
were some differences in the CD50 dose for each lineage (Table 1),
all venoms were capable of reducing cell viability of all lineages. In
addition, each venom presented a speciﬁc pattern of toxicity, with
doseeresponse curves presenting similar shape for all tested
lineages.
3.3. ELISA
In ELISA assays (Fig. 4), both Peruvian (PAV) and Brazilian (BAV)
anti-bothropic polyvalent anti-venoms strongly recognized the
different venoms coated to the plates. PAV presented a slightly
higher recognition then BAV, even with venoms that do not belong
to the antigenic pool [B. atrox (50%), B. pictus, B. barnetti, B. brazili
and Bothrocophias hyoprora 12.5%, each] used by INS to produce the
Peruvian antivenom. Pre-immune serum did not present signiﬁcant
recognition.
Fig. 2. Enzymatic activities of Peruvian Bothrops venoms. (A) Hyaluronidase activity results, measured in turbidimetric assay. Data are represented as the amount of venom needed
for degradation of 50% of hyaluronic acid, according to standard curve (means ± SEM; n ¼ 4). (B) PLA2 activity results, measured with EnzChek® Phospholipase A2 Assay Kit. Data are
represented as percentage of activity in relation to positive control of puriﬁed PLA2 (means ± SEM; n ¼ 4). (C) Metalloprotease from snake venom activity results, measured by
ﬂuorescence (lex ¼ 340 nm and lem ¼ 440 nm) produced by FRET substrate hydrolysis. Data are represented as arbitrary units of produced ﬂuorescence (means ± SEM; n ¼ 3). (D)
Serine protease from snake venom activity results, measured by ﬂuorescence (lex ¼ 340 nm and lem ¼ 440 nm) produced by FRET substrate hydrolysis. Data are represented as
arbitrary units of produced ﬂuorescence (means ± SEM; n ¼ 3). (E) L-amino acid oxidase activity results, measured in colorimetric assay at 490 nm. Data are represented as the
amount of venom that produced 1 mmol of H2O2 per minute (means ± SEM; n ¼ 4). Black arrows indicate the species who presented the highest activity for the tested enzymatic
activity.
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From SDS-PAGE (Fig. 5), it was possible to note that there are
some similarities between the venoms tested in this article.
B. chloromelas and B. oligolepis seem to have the same protein
content in their venoms. B. peruviana, which has been described as
a synonym of B. oligolepis, presented a very different band pattern.
B. castelnaudi, described elsewhere as a possible B. taeniata syno-
nym, also presented different bands.
In Western Blotting assay (Fig. 6), both Peruvian anti-bothropic
polyvalent anti-venom (PAV) and Brazilian anti-bothropic poly-
valent anti-venom (BAV) had a considerable reaction with the
Peruvian Bothrops species tested, showing full interaction with thevenoms. Reactivity intensities were comparable and both sera
recognized the majority of the bands. No reactivity was detected
when the membrane was probed with pre-immune serum (data
not shown).4. Discussion
Peru is a country with remarkable topographic diversity, and
such diversity allows the formation of a great number of different
ecosystems and microclimates, resulting in rich biodiversity. Ac-
cording to Espi~noza and Icochea (1995), there are 33 different
venomous snakes inhabiting Peruvian territory, being 9 endemic
species and another 24 shared with other countries. This makes
Fig. 3. Cell viability of MGSO-3, VERO and HeLa cells (1  104), following 24 h treatment with different concentrations of Bothrops spp. venoms (1.25e80 mg/mL). Cell viability was
analyzed by Alamar Blue® assay. Data are represented as means ± SEM (n ¼ 4).
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The Bothrops complex possesses many representatives in
Peruvian fauna. The complex presents great morphological and
ecological niches, portraying the diversity of habitats in this
country. The precise taxonomic identiﬁcation of species pertaining
to Bothrops complex (Bothrops, Bothriopsis, Bothrocophias, Rhinoc-
erophis) is still controversial (Carrasco et al., 2012), but it is accurate
to say that 97% of reported accidents with venomous snakes in Peruare caused by members of this group (Ministerio de Salud del Peru,
2003). The study of different Bothrops snakes venom composition
may help understanding the variability within these taxa as well as
the development of improved medication protocols in case of ac-
cidents, since venom toxin content can be related to clinical fea-
tures of envenomation (Queiroz et al., 2008).
The initial in vitro characterization of enzymatic activities
(HYAL, SVMP, SVSP, PLA2 and LAAO) of Peruvian bothropic venoms
Table 1
Summary of Peruvian Bothrops venom enzymatic and cytotoxic properties. Venom activities were assayed as described inMaterial andMethods and are expressed as means of
independent experiments. Hyal (hyaluronidase activity); SVMP (snake venommetalloproteinase); SVSP (snake venom serin protease); PLA2 (phospholipase activity); LAAO (L-
amino acid oxidase); CD50 (median cytotoxic dose). The gray scale represents the intensity of the detected activities.
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among the samples. It is important to stress that, although these
enzymes were chosen because they are relatively easily detected
and play key roles in the onset of bothropic envenoming, other
molecules, such as catalytically inactive Lys49 phospholipase A2
(Villalobos et al., 2007), disintegrins and C-type lectins/thrombin
inhibitors (€Ohler et al., 2010), also contribute to venom toxicity.
The compilation of the present results made possible the clas-
siﬁcation of the eleven venoms into four distinct venom proﬁles,
which may help to better characterize this group of snakes (Fig. 7).
Important differences in venom composition between members of
the Bothrops complex were already demonstrated for some Bra-
zilian species, conﬁrming that there is a high venom content vari-
ability within this group (Leme et al., 2009; Queiroz et al., 2008).
The ﬁrst identiﬁed proﬁle formed group 1 (G1), comprising
B. barnetti and B. neuwiedi, is characterized by high SVMP and low
SVSP and LAAO activities. SVMP are often the most abundant toxins
in Viperidae venoms and are the main responsible for venom's
hemorrhagic activity (reviewed by Fox and Serrano, 2009;
Markland and Swenson, 2013).
B. barnetti (Parker, 1938, known as Macanche, Sancarranca,
Doble X, Cascabel) is found along the Paciﬁc coast of northern Peru
(Fig. 9), at low elevations in arid, tropical scrub. This species venom
compose the antigenic pool used to produce Peruvian bothropic
antivenom but, in spite of this, there are not many studies con-
cerning its venom characterization (Orejuela et al., 1991; Vivas-Ruiz
et al., 2013). Its high SVMP activity justiﬁes further studies on this
species, considering it presents a high risk of causing severe
accidents.
The other member of G1, B. neuwiedi, has been referred as a
taxonomic complex, comprising 12 subspecies (Silva and
Rodrigues, 2008), with wide geographical distribution in South
America. The subspecies found in Peru was classiﬁed as B. neuwiedi
mattogrossenssis. It has been reported (Ministerio de Salud del Peru,
2003) in forest regions of eastern Andes (Fig. 9). This subspecies
venom induces lethal, myotoxic, edema-forming and deﬁbrinoge-
nating effects, in addition of being strongly hemorrhagic (Minimum
Hemorrhagic Dose of 0.90 mg) (Fernandez et al., 2010), which is in
accordance with the high SVMP activity detected in the present
analysis.
The second proﬁle (Group 2) shows high SVMP and SVSPactivities and almost undetectable HYAL activity. It is known for
long that hyaluronidase act as a venom spreading factor (Hechter,
1947). It has been demonstrated that this enzyme is crucial to
enhance venom toxicity and it is possible to say that the lack of this
enzyme may diminish mortality due to systemic complications,
conﬁning the local effects to the extent close to the snakebite
(Bordon et al., 2012; Girish et al., 2004; Mahadeswaraswamy et al.,
2011; Wahby et al., 2012). However, SVMPs can also degrade the
extracellular matrix in some extent (Gutierrez et al., 2009). In this
group, proteinases can be responsible for venom spreading, since it
presents high activity of this class, compensating the lack of HYAL
activity. HYAL properties and its role in the envenoming process
have not been extensively studied (Fox, 2013), especially within the
Bothrops complex. Only the description of a single cDNA sequence
from a hyaluronidase-like protein from Bothrops pauloensis has
been achieved so far (Castanheira et al., 2014).
G2 is composed by B. andianus and B. microphthalmus. Bothrops
andianus (Amaral, 1923, known as Andean Lancehead, Jergona,
Amantita or Marianito), is found in the southern mountains of Peru
in the departments of Cuzco and Puno, at elevations of
1800e3300 m. The geographical distribution of B. andianus over-
laps Machu Picchu's area (Peruvian Historical Sanctuary and a
UNESCOWorld Heritage Site in 1983) (Fig. 9), which receives many
tourists, putting themselves in potential risk of accidents. Our
group published an initial characterization of this venom
(Schneider et al., 2012). It was possible to detect hemorrhagic, he-
molytic and proteolytic activities, as well as cross-reactivity of
B. andianus venom with Peruvian antibothropic antivenom by
ELISA andWestern Blotting, consistent with the results shown here.
The antivenom was also capable of neutralizing the aforemen-
tioned activities. Recently, the ﬁrst serine protease with thrombin-
like activity, called TLBan, from B. andianus venomwas puriﬁed and
well characterized by Valeriano-Zapana et al., 2012. The conﬁrmed
presence of this enzyme is in accordance with the high SVSP ac-
tivity found in B. andianus venom.
In addition to be highly present in G2, SVSP activity is also
notable in G4 and in B. peruviana, from G3. This class of enzymes
causes various disturbances in the hemostatic system (platelet
aggregation, coagulation, ﬁbrinolysis, etc.) (Sajevic et al., 2011), a
characteristic sign of bothropic envenoming. SVSP with thrombin-
like activity has caught the attention of pharmaceutical industry for
Fig. 4. ELISA of venoms tested against PAV (Peruvian anti-bothropic polyvalent anti-venom), BAV (Brazilian anti-bothropic polyvalent anti-venom) and PI (pre-immune sera). All
Peruvian venoms were recognized by both antivenoms, but PAV's reaction was slightly higher, as expected. PI did not recognize any of the venoms. B. jararaca venomwas used as a
control for BAV recognition, but PAV showed higher values for this venom as well.
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Fig. 5. SDS-PAGE of Peruvian Bothrops venoms. Samples (20 mg) of B. andianus (AND),
B. atrox (ATR), B. barnetti (BAR), B. castelnaudi (CAS), B. chloromelas (CHL),
B. microphthalmus (MIC), B. neuwiedi (Peru) (NEU), B. oligolepis (OLI), B. peruviana
(PER), B. pictus (PIC)and B. taeniata (TAE), and Brazilian B. jararaca (JAR) as a reference
were analyzed in 15% polyacrylamide gel and stained with silver.
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ders (reviewed by Serrano, 2013).
The other member of G2, Bothrocophias microphthalmus (Ama-
ral, 1935, known as Jergon pudridora), is found within forests in
Colombia, Ecuador, Peru and Bolivia (Carrasco et al., 2012). This
species is also very poorly studied, but it seems to be commonly
found in Peruvian Amazonia. It occurs in sympatry with B. atrox,
and it is not clear the actual contribution of B. microphthalmus to
the accidents occurring in this area (Kuch and Freire, 1995).
B. andianus presents some features of the Bothrocophias genus,
such as small eyes and dorsal scales pattern, and its re-classiﬁcation
as belonging to this genus was proposed (Carrasco et al., 2012). The
species tested in this work supposedly pertaining to Bothrocophias
genus were put in the same enzymatic activity-deﬁned group
(Fig. 7), corroborating the phylogeny proposed by Carrasco.
Species pertaining to Group 3 (B. atrox, B. peruviana, B. pictus)
show the highest PLA2 activity. In this work, we detected only theFig. 6. Western Blotting analysis of Peruvian Bothrops venoms against Peruvian anti-both
(BAV). Samples (20 mg) of B. andianus (AND), B. atrox (ATR), B. barnetti (BAR), B. castelnaudi (C
(OLI), B. peruviana (PER), B. pictus (PIC) and B. taeniata (TAE) were analyzed in 12.5% poliacryl
or PI (1/1000) and incubated with anti-horse IgG conjugated to peroxidase. Reactivity w
substrate.catalytically active PLA2, which is responsible for venom's myo-
toxicity, inhibition of platelet aggregation (Ferreira et al., 2013;
Teixeira et al., 2011), among other deleterious effects.
G3 venoms, although not apparently related phylogenetically
(Pyron et al., 2013) nor found in neighbor regions, share a similar
eletrophoretic proﬁle (Fig. 6). B. atrox (Linnaeus, 1758, known as
Jergon, Jergona, Catari, Achujergon) is one of the better known
Peruvian species, the most toxic species from Bothrops complex
and one of the most widespread as well, covering all the Amazo-
nian region, in altitudes below 600 m (Furtado et al., 1991). In
addition, this species co-exists well with humans (Kohlhoff et al.,
2012), increasing its relevance as a health problem. Due to these
features, this snake has aroused a greater interest from researchers
(Calvete et al., 2011; Lopez-Lozano et al., 2002; Moreira et al., 2012;
Sousa et al., 2013). B. atrox venom pattern deﬁned here present high
SVMP and PLA2 activities, maybe justifying its increased venom
toxicity, since these two enzymes are responsible for many dele-
terious effects and, in addition, can act synergistically (Bustillo
et al., 2012). A previous proteomic characterization performed by
Kohlhoff et al. (2012) also found high content of these two enzymes
within Peruvian B. atrox venom.
B. pictus (Tschudi, 1845, known as Macanche, Sancarranca,
Víbora, Jergon de la Costa, Jergona) is found along the Paciﬁc coast
of Peru and the occidental Andean slope, at altitudes from sea level
to 1800 m. This region comprises the metropolitan area of Lima,
where this species is the main responsible for bothropic accidents
(Magui~na et al., 1998). This venom also integrates the antigenic pool
for Peruvian bothropic anti-venom. Taxonomically, the species
B. pictus is considered as a monophyletic group and a sister taxon to
the clade containing all other subdivisions of the Bothrops complex
(Rhinocerophis, Bothropoides, Bothriopsis, and Bothrops), accord-
ing to Pyron et al., 2013. More data are needed to better charac-
terize B. pictus venom, since it has not been the main subject of
many studies (Orejuela et al., 1991; Rojas et al., 2005). The work of
Kohlhoff et al. (2012) also described a high content of PLA2 and
SVMP in the proteomic analysis of B. pictus venom. However, unlike
our ﬁndings, they did not detect the presence of LAAO. This can be
accounted on technical sensitivity differences, since this enzyme is
found in minor amounts within bothropic venoms. Another hy-
pothesis is that the previous work was conducted with venomropic polyvalent antivenom (PAV) and Brazilian anti-bothropic polyvalent antivenom
AS), B. chloromelas (CHL), B. microphthalmus (MIC), B. neuwiedi (Peru) (NEU), B. oligolepis
amide gel, transferred to nitrocellulose membranes and probed against either PAV, BAV
as visualized using DAB/chloronaphthol according to manufacturer's instructions as
Fig. 7. Peruvian Bothrops species venom proﬁle, according to measured in vitro activities. The relative proportion of each venom activities was plotted in a piled graphic. Species
were grouped according to the similarity of its proﬁle into four groups. B. jararaca was used as a parameter.
Fig. 8. Cladogram of South American Bothropoides pitvipers, obtained in the analysis of total evidence (adapted from Carrasco et al., 2012). The species whose venom was
characterized in the present work are highlighted. The colors correspond to the group based on the established proﬁle (Red ¼ Group 1; Orange ¼ Group 2; Green ¼ Group 3;
Yellow ¼ Group 4). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 9. Main distribution of Peruvian Bothroxps species. Colored areas mark the re-
gions where the reported species are most commonly found. Round spots correspond
to punctual reports (Zamora et al., 2010; http://www.bothrops-
theultimatepitviper.com; access 01 may 2015).
C. Guerra-Duarte et al. / Toxicon 108 (2015) 84e96 93extracted from juvenile snakes, which can present signiﬁcant dif-
ferences from adult venom content (Calvete et al., 2011).
Bothriopsis peruviana (known as Jergon negro, Sachavaca
machaco) is found in southeastern Peru. Campbell and Lamar
(2004) includes this name in the synonymy of B. oligolepis
(Werner, 1901), but the lather variant is reported to be found on the
eastern slopes of the Andes in Peru and Bolivia (Quijadas-
Mascare~nas and Wüster, 2010). Analyzing these venoms' charac-
terization in this work, they presented a diverse proﬁle, consistent
with a classiﬁcation of two different species. Further information
and characterization of this species are still lacking.
Groups 4 shows very low values for SVMP activity and the
highest LAAO activity. This enzyme is present in smaller amounts
within bothropic venoms, compared to others tested here, and its
exact role in the envenoming pathophysiology remains not fully
understood (Fox, 2013). LAAO seems to be related to platelet ag-
gregation, edema formation and can exert cytotoxic effects in
bacteria, Leishmania, tumoral and normal mammalian cell lineages
(Izidoro et al., 2006; Naumann et al., 2011; Rodrigues et al., 2009;
Stabeli et al., 2007), possibly through apoptosis (Alves et al., 2008).
G4 is composed by representatives of the arboreal and semi-
arboreal Bothriopsis sub-group, including B. chloromelas,
B. oligolepis, B. taeniata, and B. castelnaudi. Unlike the members of
this group, B. taeniata also presented high PLA2 activity, but since
other features, such as cytotoxicity pattern, were more similar tothe members of this group, it was placed in G4.
Bothriopsis chloromelas (Boulenger, 1912, known as Lamon or
Achujergon) is endemic to the Central slopes of Peru, generally at
altitudes above 1000 m and has been reported as a synonym of
B. oligolepis (Schatti et al., 1990). In spite of being recognized as
possibly belonging to the same species, venoms from these snakes
were classiﬁed differently by the National Institute of Health from
Peru (INS) and analyzed separately in this work. However,
B. chloromelas and B. oligolepis presented very similar eletropho-
retic proﬁle, enzymatic activities and cytotoxicity, corroborating
the synonymy. It cannot be ruled out that previous erroneous
taxononomic classiﬁcation, which is still confusing, could have
happened and be responsible for the equivalence detected here for
these two venoms.
Bothriopsis taeniata (Wagler, 1824) is widespread in the equa-
torial forests of South America (Ecuador, Colombia, Venezuela,
Guyana, Suriname, French Guyan, Brazil, Peru and Bolivia).
B. taeniata accident was reported as a mild bothropic poisoning
without noticeable coagulopathy, but more case reports are
necessary to better characterize clinical conditions caused by this
snake (Torrez et al., 2009). This is a rather paciﬁc snake that prefers
hiding then attacking. However, considering its adult size and its
ability of injecting great amounts of venom deep in the tissues, due
to their long fangs, it can cause a potential severe harm. The low
SVMP activity detected for this venom is in accordancewith the low
coagulopathy observed, since this group of enzymes is responsible
for this type of effect.
B. castelnaudi (Dumeril, 1854) has been classiﬁed as a synonym
of B. taeniata. The presented results show that, indeed, their
venoms share some similarities, but signiﬁcant differences were
also observed, such as the high PLA2 activity of B. taeniata, which
was undetectable in B. castelnaudi venom. The present observations
hence are not sufﬁcient to state the synonymy between the two
species.
B. castelnaudi showed no in vitro coagulant activity in the work
published by Sanchez et al., 1992. It can induce weak or no ﬁbrin-
ogen clotting activity in vitro but, in vivo, it shows a high hemor-
rhagic activity. Kamigutti et al., 1985, also noted a very weak
proteolytic activity on casein and on azocoll for this venom. In the
conditions tested in this work, we have not found detectable SVMP
activity and only low SVSP activity for this venom, conﬁrming these
previous data.
Bothrops is a very diverse group and its systematic analysis is
very complex. To the moment, no consensus has been reached in
establishing a deﬁnitive phylogeny for this group. Carrasco et al.,
2012 proposed a combined analysis, using morphological, molec-
ular and ecologic features to classify South-American pitvipers
(Fig. 8). Comparing the enzymatic venom proﬁle traced in this work
and the phylogeny proposed by Carrasco, it is possible to observe
that species classiﬁed in groups 2 and 4 are in accordance with the
taxonomy and similarities detected in venom's activities may
reﬂect evolutionary proximity in these groups.
On the other hand, members of groups 1 and 3 are distant from
each other in the cladogram. It is important to stress, however, that
B. barnetti (group 1) and B. pictus (group 3) are still considered as
‘incertae sedis’, meaning that their presented classiﬁcation is not
well deﬁned. According toWüster et al., 2008, phylogenetic studies
are important to venom research and improvement of antivenom
production. In addition to this, we propose that venom composition
determination may also help phylogenetic studies, constituting an
additional feature to be considered, together with molecular,
morphological and ecology characteristics, helping to understand
evolution of the Bothrops complex. Using venom composition as
additional criteria may help deﬁning B. barnetti and B. pictus posi-
tioning in the evolutionary tree. Also, the venoms from majority of
Fig. 10. Correlation between cytotoxicity and LAAO activity. Graphs represent the results for LAAO activity of each venom plotted against the CD50values found for each cell lineage
(MGSO3, VERO and HeLa). The established correlation indicates that LAAO activity may be responsible for the observed cell toxicity.
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been characterized. Performing this kind of analysis with these
other venoms may clarify and improve the initial proﬁling pro-
posed in the present work. It is also noteworthy that B. castelnaudi
(group 4) and B. peruvianus (group 3) were not included in the
phylogenetic analysis.
In cell viability assays, all venoms were considerably toxic.
Cytotoxicity has been featured as a property of bothropic venoms in
many studies, using normal and cancer cell lineages (Jorge et al.,
2011; Mello et al., 2014; Novak-Zobiole et al., 2015; Nunes et al.,
2012). Both normal (VERO cells) and tumoral cells (MGSO-3, a
breast cancer lineage characterized within our institute; and HeLa,
cervix cancer lineage) were used in the present study, to conﬁrm
these previous ﬁndings.
In spite of using different cell lineages, the pattern of the dos-
eeresponse curve seems to be species-speciﬁc. Venoms from G1
were the least cytotoxic, whereas venoms from G4 were the most
toxic ones. It has been stated that venom cytotoxicity is related to
LAAO activity (De Vieira Santos et al., 2008). In this present work,
we found that indeed G1, in addition to being less cytotoxic, also
presented the lowest LAAO activities; and Group 4, the most
cytotoxic, also had the highest LAAO activity values. When these
features were plotted against each other (Fig.10), they showed to be
correlated (R2 > 0.64). Such correlation was not found for other
groups of activities tested in this work (R2 < 0.5).
Immunological studies of cross reactivity between the tested
venoms and different antivenoms (Peruvian e PAV, and Brazilian e
BAV) showed that in spite of the diversity of venom activities, all
venomswere recognized by the antidotes. This is a preliminary sign
that the tested antivenoms might be efﬁcient for treatment of ac-
cidents involving all of these eleven species.5. Final remarks
Peru has a remarkable biodiversity and therefore many native
species of medically relevant snakes remain poorly studied. To
assure proper care in case of accidents with less common snakes
and to expand the current knowledge on snake venoms, this work
attempted to perform an initial in vitro characterization of eleven
Peruvian snake venoms pertaining to the Bothrops complex. The
obtained results reﬂect the diversity found in nature, since different
enzymatic and antigenic proﬁles were found within the venoms
tested. Much work is still needed to properly characterize these
venoms, but the preliminary information provided here might be
useful to guide further research.Conﬂict of interest statement
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